Bone Medical Limited has appointed Michael Redman as chairman, replacing Michael Perrot who has become a non-executive director.
Immediately prior to Bone Medical, Mr Redman was the chief executive officer and co-founder of Opexa Pharmaceuticals, which commenced operations in February 2001 and was successfully sold to PharmaFrontiers in November of 2004.
His career combines sales, marketing, business and commercial development experience gained over 25 years in the pharmaceuticals and biotechnology industry. Prior to Opexa, Mr Redman held key management positions with US-based firms: Zonagen, Aronex Pharmaceuticals, Biovail, and American Home Products.
He is an active member of the Licensing Executives Society and formerly served on its executive committee.